Skip to main content

Table 3 Laboratory data

From: Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial

   Day 0 Day 2 Day 7 p value
White blood cell count, 109/L 12H 12.4 ± 3.4 8.6 ± 3.9 9.1 ± 4.0 0.585
24H 12.4 ± 4.0 7.5 ± 3.7 7.9 ± 2.8
Neutrophils, % 12H 71.2 ± 13.3 46.1 ± 18.4 40.8 ± 12.6 0.732
24H 67.2 ± 15.6 44.6 ± 19.2 40.2 ± 15.2
Platelet count, 1010/L 12H 31.1 ± 7.3 32.3 ± 10.8 54.9 ± 18.2 0.884
24H 36.2 ± 9.3 38.3 ± 11.5 58.6 ± 14.9
Albumin, g/L 12H 3.3 ± 0.4 2.7 ± 0.4 3.4 ± 0.6 0.471
24H 3.5 ± 0.4 3.0 ± 0.4 3.6 ± 0.5
Creatinine, mg/dL 12H 0.27 ± 0.06 0.24 ± 0.04 0.25 ± 0.05 0.645
24H 0.27 ± 0.07 0.26 ± 0.07 0.26 ± 0.06
Aspartate aminotransferase, U/L 12H 100 ± 159 56 ± 92 39 ± 19 0.186
24H 38 ± 21 34 ± 13 37 ± 11
Sodium, mEq/L 12H 133 ± 3 137 ± 2 138 ± 2 < 0.01
24H 137 ± 3 138 ± 3 138 ± 2
C-reactive protein, mg/dL 12H 7.3 ± 3.9 5.2 ± 3.5 0.7 ± 0.9 0.509
24H 6.4 ± 3.9 4.0 ± 5.4 0.8 ± 1.6
IgG, mg/dL 12H 624 ± 155 2414 ± 248 < 0.01
24H 754 ± 167 3037 ± 648
  1. The value of serum IgG at day 7 was excluded because the value might change depending on whether the additional IVIG was given or not
  2. Data are mean ± SD
  3. IgG indicates immunoglobulin G
  4. 12H indicates 12 h. 24H indicates 24 h